Brief: Novakand Pharma Buys SVF Vaccines
06/02/2026 07:10
Feb 6 (Reuters) - Novakand Pharma AB NOVKAN.ST: BUYS SVF VACCINES FOR 242,372,493 SHARES VALUED AT 55 MSEK SHAREHOLDERS TO RECEIVE 33.3% OF MERGED COMPANY Source text: ID:nMFN6m8JFg Further company coverage: NOVKAN.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Novakand Pharma AB
See all newsBrief: Nasdaq Decides To Delist Novakand From First North Growth Market
Brief: Novakand Pharma Extends Peter Selin's CEO Employment
Brief: Novakand Board Proposes New Business Direction, Relisting
Brief: Novakand Pharma Evaluates Options After Decision Not To Execute Reverse Take Over
Brief: Nasdaq Rejects Novakand's Application For Continued Listing